Noile-Immune Biotech (TSE:4893) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Noile-Immune Biotech's Free Cash Flow for the three months ended in Mar. 2024 was 円0.0 Mil. Noile-Immune Biotech's Revenue for the three months ended in Mar. 2024 was 円2.6 Mil. Therefore, Noile-Immune Biotech's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Noile-Immune Biotech's current FCF Yield % is -14.01%.

The historical rank and industry rank for Noile-Immune Biotech's FCF Margin % or its related term are showing as below:

TSE:4893' s FCF Margin % Range Over the Past 10 Years
Min: -771.49 Med: -292.32 Max: -17.13
Current: -280.46

During the past 4 years, the highest FCF Margin % of Noile-Immune Biotech was -17.13%. The lowest was -771.49%. And the median was -292.32%.

TSE:4893's FCF Margin % is ranked worse than
58.47% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs TSE:4893: -280.46

Noile-Immune Biotech FCF Margin % Historical Data

The historical data trend for Noile-Immune Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech FCF Margin % Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-309.06

-771.49

-17.13

-275.58

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Noile-Immune Biotech's FCF Margin %

For the Biotechnology subindustry, Noile-Immune Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noile-Immune Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Noile-Immune Biotech's FCF Margin % falls into.

Noile-Immune Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Noile-Immune Biotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-873.076	/	316.818
	=	-275.58 %

Noile-Immune Biotech's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	2.587
	=	0.00 %

Noile-Immune Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines